Canonical: https://ownershiptrace.com/13f/companies/827

# Who owns 10x Genomics, Inc. (TXG)? Elite investor 13F holders

5 tracked elite investors reported holding 10x Genomics, Inc as of 2026-06-30, including Renaissance Technologies LLC, Duquesne Family Office, D.E. Shaw, Gotham Asset Management, Bridgewater Associates. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | 10X GENOMICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 30750175.00 USD | 802039.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [Duquesne Family Office](https://ownershiptrace.com/13f/investors/30) | 10X GENOMICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 15455000.00 USD | 403100.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1536411/0001536411-26-000006-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | 10X GENOMICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 8935866.00 USD | 233069.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | 10X GENOMICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4242704.00 USD | 110660.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |
| [Bridgewater Associates](https://ownershiptrace.com/13f/investors/8) | 10X GENOMICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 512798.00 USD | 13375.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1350694/0001350694-26-000003-index.html) |
| [Ancora Advisors / Ancora Holdings](https://ownershiptrace.com/13f/investors/101) | 10X GENOMICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1446114/0001446114-26-000012-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)